ITK inhibitors (Confluence Life Sciences)

N/A

Report date: 2025/01/26 19:34:47
NME

Base Information

Drug NameITK inhibitors (Confluence Life Sciences)
Drug Alias NameIL-2 inducible T cell kinase inhibitors (Confluence Life Sciences)ITK inhibitors (Confluence)intracellular pathways modulators (Confluence)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConfluence Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesConfluence Life Sciences Inc
Inactive CompaniesAclaris Therapeutics Inc
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A